PROFENAL by Alcon is clinical pharmacology suprofen is one of a series of phenylalkanoic acids that have shown analgesic, antipyretic, and anti-inflammatory activity in animal inflammatory diseases. First approved in 1988.
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
PROFENAL (suprofen) is a nonsteroidal anti-inflammatory drug (NSAID) delivered as a 1% ophthalmic solution for use during cataract surgery. It works by inhibiting cyclooxygenase to block prostaglandin synthesis, which reduces intraocular inflammation and prevents miosis (pupil constriction) during the surgical procedure. The drug is applied topically to the eye as drops in the perioperative period.
Product approaching loss of exclusivity with minimal linked job opportunities, indicating a mature, stable team focused on maintenance rather than growth initiatives.
CLINICAL PHARMACOLOGY Suprofen is one of a series of phenylalkanoic acids that have shown analgesic, antipyretic, and anti-inflammatory activity in animal inflammatory diseases. Its mechanism of action is believed to be through inhibition of the cyclooxygenase enzyme that is essential in the…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on PROFENAL at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
PROFENAL represents a legacy ophthalmic franchise with zero linked job openings, indicating a stable but contracting team footprint. Career opportunities are primarily in commercial maintenance, regulatory compliance, and market access rather than growth or innovation functions.